↓ Skip to main content

PLOS

Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl

Overview of attention for article published in PLOS ONE, December 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
86 Mendeley
Title
Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl
Published in
PLOS ONE, December 2012
DOI 10.1371/journal.pone.0051764
Pubmed ID
Authors

Guanyu Wang, Jiawei Zhang, Luying Liu, Sherven Sharma, Qinghua Dong

Abstract

The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protection against DOX-mediated liver damage in mice.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Lebanon 1 1%
Canada 1 1%
Unknown 84 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 16%
Student > Bachelor 12 14%
Student > Master 11 13%
Researcher 8 9%
Student > Doctoral Student 5 6%
Other 13 15%
Unknown 23 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 16%
Biochemistry, Genetics and Molecular Biology 11 13%
Medicine and Dentistry 10 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Chemistry 7 8%
Other 6 7%
Unknown 30 35%